MLchartDataset catalogue

Relebactam monohydrate

Term · Oncology and biomedicine · MLC-T-ONC-016483

The monohydrate form of relebactam, a beta-lactamase inhibitor, that can be used to inhibit the breakdown of certain drugs, such as the broad spectrum beta-lactam carbapenem antibiotic imipenem. Upon administration of relebactam monohydrate, relebactam targets, binds to and inhibits beta-lactamase. This reduces the breakdown of drugs, such as imipenem, and thereby increases the activity and therapeutic effect of such drugs that would otherwise be inactivated by beta-lactamase.

Table 1. Record
IdentifierMLC-T-ONC-016483
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016483",
  "term": "Relebactam monohydrate",
  "field": "Oncology and biomedicine",
  "definition": "The monohydrate form of relebactam, a beta-lactamase inhibitor, that can be used to inhibit the breakdown of certain drugs, such as the broad spectrum beta-lactam carbapenem antibiotic imipenem. Upon administration of relebactam monohydrate, relebactam targets, binds to and inhibits beta-lactamase. This reduces the breakdown of drugs, such as imipenem, and thereby increases the activity and therapeutic effect of such drugs that would otherwise be inactivated by beta-lactamase.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/relebactam-monohydrate/"
}

Record 14,292 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.